4/A//SEC Filing
KURLAND FRED 4/A
Accession 0001104659-19-047880
CIK 0001614067other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 11:39 AM ET
Size
5.6 KB
Accession
0001104659-19-047880
Insider Transaction Report
Form 4/AAmended
KURLAND FRED
Chief Financial Officer
Transactions
- Award
Stock Options
2018-12-05+17,000→ 39,575 totalExercise: $8.50Exp: 2028-12-05→ Common Stock (17,000 underlying)
Footnotes (2)
- [F1]The shares underlying this stock option vest in equal installments over the 48 months following the date of grant. The original Form 4 stated that vesting occurred in equal annual installments over the same period.
- [F2]Due to a clerical error, the reporting person is filing this Amendment to correct the amount of derivative securities beneficially owned following the reported transaction from 39,574 to 39,575.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001267273
Filing Metadata
- Form type
- 4/A
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 11:39 AM ET
- Size
- 5.6 KB